论文部分内容阅读
目的:探讨临床治疗高尿酸血症的效果。方法:本次研究对象来源于我院2013年4月至2016年4月收治的高尿酸血症患者50例,依据治疗药物分组,其中对照组(n=25)采用别嘌醇,观察组(n=25)采用苯溴马隆,比较两组临床疗效。结果:对照组总有效率为76.0%,明显低于观察组92.0%(P<0.05);两组治疗前血尿酸水平对比P>0.05,治疗后观察组明显低于对照组(P<0.05)。结论:苯溴马隆相较于别嘌醇治疗高尿酸血症患者降血尿酸效果更优,值得推广。
Objective: To investigate the clinical effect of hyperuricemia. Methods: The study population was from 50 patients with hyperuricemia admitted from April 2013 to April 2016 in our hospital. Patients in the control group (n = 25) were treated with allopurinol and the observation group (n = n = 25) with benzbromarone, the clinical efficacy of two groups were compared. Results: The total effective rate in the control group was 76.0%, which was significantly lower than that in the observation group (92.0%, P <0.05). The levels of serum uric acid in the two groups before treatment were significantly higher than those in the control group (P <0.05) . Conclusion: Benzbromarone is better than ubiquitin in the treatment of hyperuricemia in patients with hyperuricemia, which is worth promoting.